small molecule

TRAVASOL 8.5% W/ ELECTROLYTES

AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRAVASOL 8.5% W/ ELECTROLYTES
Active ingredientAMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE
Strength8.5%;102MG/100ML;522MG/100ML;594MG/100ML;154MG/100ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.